Adenosine amine congener

• Product Name Alternative:

  ADAC

• UNSPSC Description:

  Adenosine amine congener (ADAC) is a selective A1 adenosine receptor agonist, can ameliorate noise- and Cisplatin-induced cochlear injury. Adenosine amine congener also has neuroprotective effects[1][2].

• Target Antigen:

  Adenosine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Field of Research:

  Inflammation/Immunology; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/adenosine-amine-congener.html

• Purity:

  99.23

• Solubility:

  DMSO : 31.25 mg/mL (ultrasonic)

• Smiles:

  O=C(NC1=CC=C(CC(NCCN)=O)C=C1)CC2=CC=C(NC3=NC=NC4=C3N=CN4[C@@H]5O[C@H](CO)[C@@H](O)[C@H]5O)C=C2

• Molecular Weight:

  576.60

• References & Citations:

  [1] Vlajkovic SM, et al. Adenosine amine congener as a cochlear rescue agent. Biomed Res Int. 2014;2014:841489.|[2]Vlajkovic SM, et al. Adenosine amine congener mitigates noise-induced cochlear injury. Purinergic Signal. 2010 Jun;6(2):273-81.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  96760-69-9